Additionally, the 5-HT1A receptor, which modulates neuronal firing rates, has emerged as a potential target for treating motor deficits in FXS, given its association with neurodevelopmental disorders [53,54,76]. The gene discussed is HTR1A; the disease is fragile X syndrome.